Steven J Prior1, Alice S Ryan2, Jacob B Blumenthal2, Jonathan M Watson2, Leslie I Katzel2, Andrew P Goldberg2. 1. Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore. Baltimore Veterans Affairs Geriatric Research, Education and Clinical Center, and Research and Development Service, Baltimore, Maryland. sprior@grecc.umaryland.edu. 2. Division of Gerontology and Geriatric Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore. Baltimore Veterans Affairs Geriatric Research, Education and Clinical Center, and Research and Development Service, Baltimore, Maryland.
Abstract
BACKGROUND: Skeletal muscle capillary rarefaction limits the transcapillary transport of nutrients and oxygen to muscle and may contribute to sarcopenia and functional impairment in older adults. We tested the hypothesis that skeletal muscle capillarization and exercise capacity (VO2max) are lower in sarcopenic than in nonsarcopenic older adults and that the degree of sarcopenia is related to lower skeletal muscle capillarization. METHODS: Body composition, VO2max, and vastus lateralis capillarization were determined in 76 middle-aged and older men and women (age = 61±1 years, body mass index [BMI] = 30.7±0.5kg/m(2) [mean ± SEM]). Participants were classified as sarcopenic if appendicular lean mass divided by BMI (ALMBMI) was less than 0.789 for men or less than 0.512 for women. RESULTS: Sarcopenic subjects (ALMBMI = 0.65±0.04, n = 16) had 20% lower capillary-to-fiber ratio, as well as 13% and 15% lower VO2max expressed as mL/kg/min or L/min, respectively, compared with sex-, race-, and age-matched participants without sarcopenia (ALMBMI = 0.81±0.05, n = 16; p < .05). In all 76 subjects, ALMBMI, thigh muscle cross-sectional area, and VO2max correlated directly with capillarization (r = .30-.37, p ≤ .05), after accounting for age, sex, and race. CONCLUSIONS: These findings suggest that low skeletal muscle capillarization is one factor that may contribute to sarcopenia and reduced exercise capacity in older adults by limiting diffusion of substrates, oxygen, hormones, and nutrients. Strategies to prevent the aging-related decline in skeletal muscle capillarization may help to prevent or slow the progression of sarcopenia and its associated functional declines in generally healthy older adults. Published by Oxford University Press on behalf of the Gerontological Society of America 2016.
BACKGROUND: Skeletal muscle capillary rarefaction limits the transcapillary transport of nutrients and oxygen to muscle and may contribute to sarcopenia and functional impairment in older adults. We tested the hypothesis that skeletal muscle capillarization and exercise capacity (VO2max) are lower in sarcopenic than in nonsarcopenic older adults and that the degree of sarcopenia is related to lower skeletal muscle capillarization. METHODS: Body composition, VO2max, and vastus lateralis capillarization were determined in 76 middle-aged and older men and women (age = 61±1 years, body mass index [BMI] = 30.7±0.5kg/m(2) [mean ± SEM]). Participants were classified as sarcopenic if appendicular lean mass divided by BMI (ALMBMI) was less than 0.789 for men or less than 0.512 for women. RESULTS: Sarcopenic subjects (ALMBMI = 0.65±0.04, n = 16) had 20% lower capillary-to-fiber ratio, as well as 13% and 15% lower VO2max expressed as mL/kg/min or L/min, respectively, compared with sex-, race-, and age-matched participants without sarcopenia (ALMBMI = 0.81±0.05, n = 16; p < .05). In all 76 subjects, ALMBMI, thigh muscle cross-sectional area, and VO2max correlated directly with capillarization (r = .30-.37, p ≤ .05), after accounting for age, sex, and race. CONCLUSIONS: These findings suggest that low skeletal muscle capillarization is one factor that may contribute to sarcopenia and reduced exercise capacity in older adults by limiting diffusion of substrates, oxygen, hormones, and nutrients. Strategies to prevent the aging-related decline in skeletal muscle capillarization may help to prevent or slow the progression of sarcopenia and its associated functional declines in generally healthy older adults. Published by Oxford University Press on behalf of the Gerontological Society of America 2016.
Authors: Thomas W Buford; Stephen D Anton; Andrew R Judge; Emanuele Marzetti; Stephanie E Wohlgemuth; Christy S Carter; Christiaan Leeuwenburgh; Marco Pahor; Todd M Manini Journal: Ageing Res Rev Date: 2010-05-14 Impact factor: 10.895
Authors: William Kyle Mitchell; Bethan E Phillips; John P Williams; Debbie Rankin; Kenneth Smith; Jonathan N Lund; Philip J Atherton Journal: Physiol Rep Date: 2013-10-27
Authors: Abhirup Das; George X Huang; Michael S Bonkowski; Alban Longchamp; Catherine Li; Michael B Schultz; Lynn-Jee Kim; Brenna Osborne; Sanket Joshi; Yuancheng Lu; Jose Humberto Treviño-Villarreal; Myung-Jin Kang; Tzong-Tyng Hung; Brendan Lee; Eric O Williams; Masaki Igarashi; James R Mitchell; Lindsay E Wu; Nigel Turner; Zolt Arany; Leonard Guarente; David A Sinclair Journal: Cell Date: 2018-03-22 Impact factor: 41.582
Authors: Tatiana Moro; Camille R Brightwell; Danielle E Phalen; Colleen F McKenna; Samantha J Lane; Craig Porter; Elena Volpi; Blake B Rasmussen; Christopher S Fry Journal: Exp Gerontol Date: 2019-09-10 Impact factor: 4.032
Authors: Alistaire D Ruggiero; Ashley Davis; Chrissy Sherrill; Brian Westwood; Gregory A Hawkins; Nicholette D Palmer; Jeff W Chou; Tony Reeves; Laura A Cox; Kylie Kavanagh Journal: Am J Physiol Regul Integr Comp Physiol Date: 2020-11-18 Impact factor: 3.619
Authors: Aliza B Rubenstein; J Matthew Hinkley; Venugopalan D Nair; German Nudelman; Robert A Standley; Fanchao Yi; GongXin Yu; Todd A Trappe; Marcas M Bamman; Scott W Trappe; Lauren M Sparks; Bret H Goodpaster; Rick B Vega; Stuart C Sealfon; Elena Zaslavsky; Paul M Coen Journal: Am J Physiol Endocrinol Metab Date: 2022-01-24 Impact factor: 4.310
Authors: Odessa Addison; Steven J Prior; Rishi Kundi; Monica C Serra; Leslie I Katzel; Andrew W Gardner; Alice S Ryan Journal: Arch Phys Med Rehabil Date: 2017-11-11 Impact factor: 4.060